⌕
Disc Medicine · IRON · Nasdaq
Tenet 49 · Mixed
Compare
$76.57−0.03%At closeTenet 49 · Mixed
$76.57−0.02 (−0.03%)
At close: Nov 17, 2026, 4:00 PM ET· Nasdaq · USD

Disc Medicine (IRON) Institutional Ownership

13F filers reported holding 35.3% of Disc Medicine (IRON) shares as of Sep 30, 2026, across 115 filers.

Sources Ownership filingsQuarter ended How we compute thisNot investment advice
Held by 13F filers
35.3%
Sep 30, 2026
13F filers
115
quarter ended Sep 30, 2026
13F value
$1.1B
16.1M shares
Quarter's fund flow
Mild accumulation
23 new · 11 closed

Is the smart money (institutions and insiders) accumulating or distributing? One lagging input, not a buy signal.

13F fund flowQuarter ended Sep 30, 2026: more funds added or entered than trimmed or exited, mild accumulation (23 new · 40 increased · 32 reduced · 11 closed · 9 unchanged or with no prior quarter on file). Flows at this scale move slowly; treat as context. These positions are 49 days old; the 45-day figure often quoted is the SEC filing deadline after quarter-end, not the age of the data. The counts above compare each filer’s position with its own previous 13F. The change in the number of filers and in the ownership share is not shown: the filings we read hold only each filer’s latest 13F, so there is no earlier quarter of the same filers to compare against. That is a limit of the source, not a statement about this company.
Basis: shares reported by 115 13F filers for Sep 30, 2026, over shares outstanding implied from the current quote, measured 49 days apart. It measures the ownership we have filings for, not total institutional ownership, and it moves with the share count between filings.
routine sells are usually compensation mechanics; open-market buys are the rarer signal. Rows labelled with another security are the derivative leg of a vest or exercise, not share sales
DateNameRoleTypeSharesPriceSEC filing
Oct 21, 2026Bitterman KevindirectorDisposed · Open-market sale13,783$80.23↗
Oct 21, 2026Bitterman KevindirectorDisposed · Open-market sale11,470$80.23↗
Oct 21, 2026Bitterman KevindirectorDisposed · Open-market sale266$80.23↗
Oct 20, 2026Bitterman KevindirectorDisposed · Open-market sale2,869$79.95↗
Oct 20, 2026Bitterman KevindirectorDisposed · Open-market sale2,388$79.95↗
Oct 20, 2026Bitterman KevindirectorDisposed · Open-market sale55$79.95↗
Oct 19, 2026Bitterman KevindirectorDisposed · Open-market sale5,937$79.97↗
Oct 19, 2026Bitterman KevindirectorDisposed · Open-market sale4,942$79.97↗
Oct 19, 2026Bitterman KevindirectorDisposed · Open-market sale115$79.97↗
Sep 15, 2026Quisel John DChief Executive OfficerAcquired · Option exercise36,000$1.01↗
Sep 15, 2026Quisel John DChief Executive OfficerDisposed · Option exercise36,000Stock Option (Right to Buy)—↗
Sep 11, 2026Bitterman KevindirectorAcquired · Option exercise7,136$45.69↗
Sep 11, 2026Bitterman KevindirectorAcquired · Option exercise10,000$38.85↗
Sep 11, 2026Bitterman KevindirectorAcquired · Option exercise10,000$50.86↗
Sep 11, 2026Bitterman KevindirectorDisposed · Open-market sale27,136$70.11↗
Sep 11, 2026Bitterman KevindirectorDisposed · Option exercise7,136Stock Option (Right to Buy)—↗
Sep 11, 2026Bitterman KevindirectorDisposed · Option exercise10,000Stock Option (Right to Buy)—↗
Sep 11, 2026Bitterman KevindirectorDisposed · Option exercise10,000Stock Option (Right to Buy)—↗
Sep 4, 2026Bitterman KevindirectorDisposed · Open-market sale912$79.96↗
Sep 4, 2026Bitterman KevindirectorDisposed · Open-market sale759$79.96↗

* Holdings as reported for Sep 30, 2026, 49 days old; funds file up to 45 days after each quarter-end, so the newest complete quarter runs 45 to 135 days behind.

** A price of “—” marks an option exercise, RSU vest or a filing without a usable per-share price, not a $0 trade.

How much of Disc Medicine do institutions hold?

13F filers reported holding 35.3% of Disc Medicine's shares as of Sep 30, 2026, across 115 filers.

How many 13F filers hold Disc Medicine?

Disc Medicine was held by 115 13F filers as of Sep 30, 2026.

Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.